Although low GOT2 expression appeared to be significantly correlated with favourable patient survival in HPV- HNSCC (p = 0.029; Figure 4F), it lost its significance after correcting for FDR (q = 0.20). This evidence concerns the gene GOT2 and head and neck squamous cell carcinoma.